TABLE 13-46. SURVEILLANCE DEFINITION FOR CONGENITAL SYPHILIS
| TABLE 13-46. SURVEILLANCE DEFINITION FOR CONGENITAL SYPHILIS |
|
Confirmed Demonstration of T. pallidum identified by darkfield microscopy, fluorescent antibody, or other specific stains in specimens from lesions, placenta, umbilical cord, or autopsy material. Probable Any infant whose mother had untreated or inadequately treated (not with penicillin) syphilis at delivery, regardless of signs in the infant. Any infant (or child) who has a reactive treponemal test for syphilis plus one of the following: Physical signs of congenital syphilis Radiologic findings of congenital syphilis (long bones) Reactive VDRL in the CSF Elevated CSF cell count or protein (not otherwise explained) Reactive FTA-ABS-19S-IgM antibody test or IgM enzyme-linked immunosorbent assay |
| VDRL = Venereal Disease Research Laboratories; FTA-ABS-IgM = fluorescent treponemal antibody immunoglobulin M. |